Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for VTIAF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
March 31, 2026 1.006M
December 31, 2025 4.816M
September 30, 2025 -1.182M
June 30, 2025 1.358M
March 31, 2025 -0.4631M
December 31, 2024 -1.108M
September 30, 2024 0.4955M
June 30, 2024 -0.0877M
March 31, 2024 -5.672M
December 31, 2023 3.211M
September 30, 2023 -5.480M
June 30, 2023 0.6693M
March 31, 2023 -2.512M
December 31, 2022 -4.440M
September 30, 2022 0.2516M
June 30, 2022 -2.416M
March 31, 2022 -2.284M
December 31, 2021 2.440M
September 30, 2021 -1.655M
June 30, 2021 -0.647M
March 31, 2021 -0.6384M
December 31, 2020 -0.4742M
September 30, 2020 -0.6843M
June 30, 2020 -0.5768M
March 31, 2020 -0.6324M
Date Value
December 31, 2019 -0.6296M
September 30, 2019 -0.6349M
June 30, 2019 -1.388M
March 31, 2019 -0.4576M
December 31, 2018 -0.5169M
September 30, 2018 -0.5211M
June 30, 2018 -1.983M
March 31, 2018 -0.0885M
December 31, 2017 -0.6475M
September 30, 2017 5.603M
June 30, 2017 10.33M
March 31, 2017 -0.0533M
December 31, 2016 -0.333M
September 30, 2016 -0.5871M
June 30, 2016 -0.0677M
March 31, 2016 -0.1058M
December 31, 2015 0.1729M
September 30, 2015 -0.5569M
June 30, 2015 -0.0586M
March 31, 2015 0.9151M
December 31, 2014 -0.0012M
September 30, 2014 0.0159M
June 30, 2014 0.2482M
March 31, 2014 -0.0274M
December 31, 2013 -0.3226M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Fresenius Medical Care AG -903.96M
Global Cord Blood Corp. --
Cryo-Cell International, Inc. -1.623M
Rhön-Klinikum AG --
Cordlife Group Ltd. -0.3943M